Atlas Trials

A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

Clinical trial NCT00454636 · COMPLETED

Trial details

NCT number
NCT00454636
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2007-03-01
Primary completion
2010-07-01
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.